Professional Documents
Culture Documents
Syifaa'.Wani - Shera.Achik - Syaa.Alin - Anis.Fatin - Yaya. THE 9 X-VIBRANT2017
Syifaa'.Wani - Shera.Achik - Syaa.Alin - Anis.Fatin - Yaya. THE 9 X-VIBRANT2017
1 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
2. Look at the picture.
A B
e) What and when the next investigation should be done in the ‘high-risk’ group?
Detailed ultrasound scan (USS) at 20 – 22 weeks of gestation; looking for
structural fetal anomalies
2 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
3. Look at the picture given: Prostin E2 (Dinoprostone)
i- Uterine hyperstimulation
c) State 2 parameters used to monitor patient after the usage of above drug (2 marks)
ii- ECG
d) Name other methods/devices used for the same indication as the above drug (3 marks)
3 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
4 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
4. Look at the picture.
c) 3 signs you would like to observe when performing this procedure (3 marks)
i- Gushing of blood per vaginally
ii- Lengthening of cord 3 Signs of placental separation
iii- Hard globular uterus
5 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
5. MgSO4 ampule
a) 3 indications (3 marks)
i- Treat & prevent eclampsia
ii- As neuroprotection
iii- As tocolytic
d) What is the name and dosage of drug given when toxicity occurred?
IV 10mls of 10% Calcium gluconate
6 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
6.
b) 2 indications (2 marks)
i- Artificial Rupture of membrane - amniotomy (IOL)
ii- Guided fetal electrode of internal CTG
7 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
7. Picture of partogram.
i. Maternal information: Name, Gravida & Para, POA, brief antenatal issues
8 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
8. Look at the picture.
d) 2 Contraindications (2 marks)
i- Patient not in labour
ii- Intact fetal membrane
iii- Placenta praevia
iv- High risk mother (HIV, active herpes)
v- Mother’s not keen
9 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
9. Look at the picture
A B C
a) Name the instrument (3 marks)
A: Silastic cup ventouse
B: Metal cup ventouse
C: Kiwi cup
Maternal Fetal
i. Maternal exhaustion v- Fetal distress in 2nd stage of labour
ii. Prolonged 2nd stage of labour
iii. Mother with heart disease
(Heart failure, severe PE,
HPT)
10 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
10. Look at the picture. Cephalic curve
Shanks
Handle
Lock
A B C
Maternal Fetal
i. Maternal exhaustion iv. Fetal distress in 2nd stage of
ii. Prolonged 2nd stage of labour labour
iii. Mother with heart disease
(Heart failure, severe PE,
HPT)
11 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
11. Look at the picture.
12 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
Look at the picture: NIFEDIPINE (CCB)
As tocolytic: reduce calcium (Ca²⁺) influx into the cells; subsequently reducing
uterine smooth muscle contractility.
13 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
12.
14 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
13. Look at the picture
15 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
14. Look at type of breech presentation.
A B C
Piper’s forcep
a) Label the picture (3 marks)
A: Flexed-breech presentation
B: Extended-breech presentation
C: Footling-breech presentation
b) What is the type of breech that can be delivered per vaginally? (2 marks)
A & B (Flexed & Extended Breech)
d) Name the instrument that can be used to deliver the upcoming head? (1 mark)
Piper’s forcep
16 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
15. Look at the partogram.
17 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
16. Look at the picture
A B
a) What are (A) & (B)? (2 marks)
A: Cord presentation
B: Cord prolapse
Iatrogenic (ARM when head is not engage, station is high or cord presentation)
Maternal Fetal
CPD IUGR/SGA
Multiparity Malpresentation/abnormal lie
Pelvic mass in pregnancy Polyhydromnios
PPROM/PROM/SROM
18 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
17. Look at the picture.
19 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
18. Look at the CTG.
20 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
19. Look at the CTG.
21 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
20. Look at the CTG
22 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7
21. Look at the picture
c) What are the mode of administration and the effective dose? (2 marks)
Start with: IV terbutaline 2.5 – 5 mcg/min (*increase gradually over 20- 30 min
intervals)
Typical effective dose: 17.5 – 30 mcg/min (some require up to: 70 – 80 mcg/min)
Continue infusion over 12 H following cessation of uterine contraction
(Max up to: < 48 – 72 H); but in patient with kidney dz (GFR < 50mL/min dose need to be
↓ 50%)
23 | S y i f a a ’ . W a n i . S h e r a . A c h i k . S y a a . A l i n . A n i s . F a ti n . Y a y a . * T H E 9 * X - V I B R A N T 2 0 1 7